Cui Xiaorui, Li Mingpeng, Lei Guanxiong, Wang Jie, Pan Jialin, Zhu Sheng, Wu Tao, Zou Liangyu, Yan Jianhui
Department of Neurology, Affiliated Hospital of Xiangnan University, Chenzhou, China.
Department of Cardiovascular, Chenzhou No.1 People's Hospital, The First Affiliated Hospital of Xiangnan University, Chenzhou, China.
Front Aging Neurosci. 2024 Dec 4;16:1453051. doi: 10.3389/fnagi.2024.1453051. eCollection 2024.
Brain has been shown to undergo progressive atrophy in patients with Alzheimer's disease (AD); however, more evidence is needed to elucidate how the brain structure changes during the progression to AD. Here, we observed differences in the cerebral structure among patients with amnestic mild cognitive impairment (aMCI) and patients with AD.
A total of 46 participants were selected and divided into AD, aMCI, and healthy control (HC) groups. Structural magnetic resonance imaging (sMRI) was performed on all participants. Voxel-based morphometry (VBM) and surface-based morphometry (SBM) techniques were utilized to analyze sMRI data so as to identify significant differences among the specific brain regions of these three groups. Then, a correlation analysis was performed on the characteristics of the identified brain regions and the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) cognitive assessment scores.
The volume of the left precuneus region, which was identified by voxel-based morphometry, and the thickness of both sides of the inferior parietal, which was identified by surface-based morphometry, were shown to be less in AD/aMCI patients, compared to those of the HC. The correlation analysis showed that there were significant differences between the volume of the left precuneus region and the MMSE/MoCA scores, as well as between the thickness of the left and right sides of the inferior parietal region and the MMSE/MoCA scores.
The sMRI characteristics of the identified brain regions were considered to be potential predictive diagnostic biomarkers for AD.
Identifier: ChiCTR2400092593.
已有研究表明,阿尔茨海默病(AD)患者的大脑会逐渐萎缩;然而,仍需要更多证据来阐明在向AD进展过程中大脑结构是如何变化的。在此,我们观察了遗忘型轻度认知障碍(aMCI)患者和AD患者之间的脑结构差异。
共选取46名参与者,将其分为AD组、aMCI组和健康对照组(HC)。对所有参与者进行了结构磁共振成像(sMRI)检查。利用基于体素的形态测量(VBM)和基于表面的形态测量(SBM)技术分析sMRI数据,以确定这三组特定脑区之间的显著差异。然后,对所确定脑区的特征与简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)认知评估得分进行相关性分析。
基于体素的形态测量法确定的左侧楔前叶区域体积,以及基于表面的形态测量法确定的双侧顶下叶厚度,AD/aMCI患者均小于HC组。相关性分析表明,左侧楔前叶区域体积与MMSE/MoCA得分之间,以及顶下叶区域左右两侧厚度与MMSE/MoCA得分之间存在显著差异。
所确定脑区的sMRI特征被认为是AD潜在的预测性诊断生物标志物。
标识符:ChiCTR2400092593。